Renal Function and Chronic Allograft Vasculopathy
1 clinical trials · Condition
◉ Watch Renal Function and Chronic Allograft Vasculopathy
| Record | Firm | Date |
|---|---|---|
| SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance (NCT01266148) | Novartis Pharmaceuticals | 2009-11-01 |
Track Renal Function and Chronic Allograft Vasculopathy automatically
Every clearance here is in the API, with alerts when new ones post.